To characterize the role of neurotransmitters, neuropeptides, neurotrophic factors, and axonal guidance molecules in breast cancer progression, we analyzed the expression of several neurogenes in breast cancer patients and in CD44 and CD24 expression databases. Here, CD44 is linked to breast cancer.